Background: Takayasu arteritis (TAK) is a large vessel vasculitis of unknown etiology, predominantly affecting the aorta and/or its major branches and occurring before the age of 40 years.TAK has been described worldwide with an annual incidence in Europe ranging from 0.4 to 1.3 /1.000.000. TAK is more common in female. In the largest study from Japan, the female to male ratio was eight to one. In a recent Swedish epidemiologic study no male were identified. There are no epidemiological studies regarding Takayasu arteritis in Italian population. Objectives: To investigate the epidemiology of Takayasu arteritis in a Northern Italy area. Methods: All patients with incident TAK diagnosed between 1997 and 2015 living in the Reggio Emilia area were identified by capture and re-capture checking at computerized discharge diagnosis codes (ICD10) and at outpatients databases from rheumatology, internal medicine, surgery, pathology, imaging departments of Reggio Emilia Hospital and by examining the Reggio Emilia district database for rare diseases.The Reggio Emilia population is predominantly of Caucasian origin (92.5%) with a yearly increase in general population of 0.5% (from 438.588 inhabitants in 1997 to 533.827 in 2015). Results: There were 5 women satisfyng ACR 1990 criteria for TAK diagnosis during the 18 years study period. The overall age and sex-adjusted 18 years incidence per 100.000 persons aged <40 years was 2.2. (95% CI:0.71 to 5.09). The overall age-and sex-adjusted 20 years incidence per 100,000 women aged <40 years was 4.5. (95% CI:1.46 to 10.48). Median age at disease onset was 36y and at diagnosis was 39 years. The prevalence of TAK in the general population on December 31 2015 was 0.9 (95% CI: 0.31 to 2.19) while in female population aged <40 years was 4.4 (95% CI 1.47 to 10.54). All patients are still alive on December 31 2015. Objectives: Cardiovascular complications are the main causes of morbidity and mortality in the course of Takayasu arteritis (TA).In addition to the occlusive vasculitis,hypertension and accelerated atherosclerosis are possibly other factors playing role in the ethiopathogenesis of these complications.Although,strict management of traditional cardiovascular risk factors is advocated to diminish the effect of cardiovascular complications,we still do not know whether traditional risk factors and other comorbid conditions are increased or operative.In this study we looked at the frequency of traditional atherosclerotic risk factors and comorbid conditions among patients with TA and suitable diseased and healthy controls. Methods: We studied 88 (77F,11M) consecutive TA patients and 71 (66F,5M) SLE patients,between May and November 2016.In addition,age and gender matched, 96 (80F, 16M) healthy controls were included.Study participants were interviewed with the help of a standardized questionnaire that assess the presence or absence of traditional atherosclerotic risk factors and several comorbid conditions according to the Charlson comorbidity index.Additionally,Framingham coronary heart disease risk score was calculated. Results: Smoking was more frequent among the healthy controls,whereas hypertension and family history of cardiovascular diseases were more common among TA patients.Patients with SLE were found to have less hyperlipidemia.The Framingham risk scores did not differ among the groups.Pericardial/pleural and renal diseases were more frequently observed in SLE patients,whereas cardiovascular diseases and chronic lung diseases were more common in TA patients.Inflammatory bowel diseases were only observed in TA patients.
Conclusions

